2024-09-21 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacy, pharmacy benefit management, and healthcare services businesses.

**Performance Analysis:**

1. **Performance vs. S&P 500 (VOO):** CVS has significantly underperformed the S&P 500 (VOO) over the period analyzed, with a cumulative return of -33.88% compared to VOO's 133.16%. This results in a substantial divergence of -167.04, placing CVS in the bottom percentile of performance relative to the benchmark index. 

2. **Recent Price Movements:** CVS's recent price action suggests a period of consolidation. 
    * **Closing Price:** $58.28
    * **5-Day Moving Average:** $58.15
    * **20-Day Moving Average:** $57.72
    * **60-Day Moving Average:** $58.28

3. **Technical Indicators:**
    * **RSI (Relative Strength Index):** 56.39 -  Indicates a neutral to slightly overbought territory, suggesting potential for price consolidation or a slight pullback.
    * **PPO (Percentage Price Oscillator):** 0.25 - Shows a positive momentum, although its value is relatively low, suggesting a less pronounced upward trend.
    * **Delta_Previous_Relative_Divergence:** -2.04 -  Indicates a recent short-term decline in relative performance. 
    * **Expected_Return:** 14.59% -  Suggests a potential for a 14.59% return over the next 5-10 years, based on current investment levels. 

4. **Recent Earnings and Outlook:** CVS's recent earnings have generally met or slightly surpassed expectations. 

| Date  | EPS  | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report shows that CVS beat expectations, reporting an EPS of 1.83 against an expected EPS of 1.73. While CVS has consistently met or exceeded earnings expectations, the stock's performance has been significantly affected by broader market trends and concerns about the healthcare sector.

**Overall Analysis:**

CVS Health Corp has significantly underperformed the broader market over the period analyzed. Although its recent earnings performance has been solid, it's important to acknowledge the stock's current valuation, which is likely reflecting concerns about the healthcare sector and its long-term growth prospects. While the technical indicators suggest potential for consolidation or a slight pullback, the expected return of 14.59% over 5-10 years could be appealing for long-term investors willing to accept the stock's volatility. 
